$10.77
近くで: Sep 24, 5:00 PM EST
$10.97
0.201.86%
時間外: 9:27 AM EST
Benzinga
Benzinga
Benzinga
木曜日, 9 24
Pharming Group
PHARNASDAQ
Pharming Earnings & Forecasts
Pharming (PHAR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pharming Guidance
Pharming (PHAR) は、7 30, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$375M - $395Mの範囲と予想しています。
以前のガイダンスと比較して、Pharmingは売上高予測を以前の範囲である引き下げから$405M - $425Mに引き上げました。
Pharmingは、13から1 8, 2024の間に7 30, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 7 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.09 | $0.01 | $0.07 | $0.02 |
| Actual | $0.02 | $-0.07 | $0.07 | $0.10 |
| Surprise | -77.8% | -800.0% | 0.00% | +400.0% |
| Revenue | ||||
| Estimate | $101.2M | $92.4M | $95.7M | $84.8M |
| Actual | $90.2M | $72.4M | $106.5M | $97.3M |
| Surprise | -10.8% | -21.6% | +11.2% | +14.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $0.18 | $0.25 | $-0.10 |
| Revenue | |||
| Consensus | $103.4M | $115.6M | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved